Literature DB >> 3754025

Hypercalcemia and elevated serum 1,25-dihydroxyvitamin D3 in a patient with Hodgkin's lymphoma.

K Schaefer, J Saupe, A Pauls, D von Herrath.   

Abstract

A 74-year-old woman was hospitalized because of decreased appetite, fatigue, and weight loss. The laboratory examination revealed hypercalcemia, a slightly increased serum creatinine level, and a markedly elevated serum level of 1,25-dihydroxyvitamin D3. The most important finding the physical examination revealed was enlarged inguinal lymph nodes. A biopsy disclosed lymphocyte-depleted Hodgkin's disease. After steroids, but not after calcitonin, both the elevated calcitriol concentration and serum calcium normalized. In spite of intensive chemotherapy, a further episode with hypercalcemia occurred and increased 1,25-dihydroxyvitamin D3 serum levels were observed. According to the available evidence it seems probable that the humoral hypercalcemia in this patient resulted from production of 1,25-dihydroxyvitamin D3 in the tumor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3754025     DOI: 10.1007/bf01784135

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  7 in total

1.  Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma.

Authors:  N A Breslau; J L McGuire; J E Zerwekh; E P Frenkel; C Y Pak
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

2.  Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis.

Authors:  P J Gkonos; R London; E D Hendler
Journal:  N Engl J Med       Date:  1984-12-27       Impact factor: 91.245

3.  Abnormal vitamin D metabolism in Hodgkin's lymphoma.

Authors:  M Davies; E B Mawer; M E Hayes; G A Lumb
Journal:  Lancet       Date:  1985-05-25       Impact factor: 79.321

4.  Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.

Authors:  N H Bell; P H Stern; E Pantzer; T K Sinha; H F DeLuca
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

5.  Humoral hypercalcemia in Hodgkin's disease. Association with elevated 1,25-dihydroxycholecalciferol levels and subperiosteal bone resorption.

Authors:  G P Zaloga; C Eil; C A Medbery
Journal:  Arch Intern Med       Date:  1985-01

6.  Elevations in circulating 1,25-dihydroxyvitamin D in three patients with lymphoma-associated hypercalcemia.

Authors:  N Rosenthal; K L Insogna; J W Godsall; L Smaldone; J A Waldron; A F Stewart
Journal:  J Clin Endocrinol Metab       Date:  1985-01       Impact factor: 5.958

7.  1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis.

Authors:  S E Papapoulos; T L Clemens; L J Fraher; I G Lewin; L M Sandler; J L O'Riordan
Journal:  Lancet       Date:  1979-03-24       Impact factor: 79.321

  7 in total
  2 in total

1.  Intermittent hypercalcaemia and vitamin D sensitivity in Hodgkin's disease.

Authors:  R Karmali; S Barker; M Hewison; L Fraher; D R Katz; J L O'Riordan
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

Review 2.  Animal Models of Cancer-Associated Hypercalcemia.

Authors:  Nicole A Kohart; Said M Elshafae; Justin T Breitbach; Thomas J Rosol
Journal:  Vet Sci       Date:  2017-04-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.